Clinical Trial Update: The Individualized M(X) Drug-resistant TB Treatment Strategy Study [Phase 4]

View source ↗

Summary

Phase 4 trial update for an individualized M(X) drug-resistant TB treatment strategy; the study is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis Multidrug-resistant

Snippet

Sponsor: Centre for the AIDS Programme of Research in South Africa | Conditions: Tuberculosis, Multidrug-Resistant | Phase 4 | Status: TERMINATED